Increased expression of IL-18 in the serum and islets of type 1 diabetics

Robert Z. Harms, Danielle N. Yarde, Zachary Guinn, Kristina M. Lorenzo-Arteaga, Kevin P. Corley, Monina S. Cabrera, Nora E Sarvetnick

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Type 1 diabetes (T1D) is a chronic disease characterized by autoimmune-mediated destruction of pancreatic insulin-producing beta cells. Interleukin (IL)-18 is a pro-inflammatory cytokine implicated in the pathogenesis of a number of inflammatory diseases. Here, we analyzed IL-18 levels in the plasma of juveniles with T1D. Compared to control subjects, IL-18 levels were significantly elevated in patients with T1D. On the other hand, levels of IL-18 binding protein (IL-18BP) and IL-37, two negative regulators of IL-18 function, remained unchanged when comparing T1D to control samples. Notably, however, although IL-18BP levels were not elevated, IL-18 and IL-18BP were found to be positively correlated in type 1 diabetics. Even so, free, unbound IL-18 remained significantly increased in diabetic patients. Additionally, correlation studies also revealed that IL-18 and IL-18BP are positively correlated with HbA1c levels in T1D patients, suggesting a potential link between IL-18 and metabolic control in these patients. Finally, we observed a significant increase in IL-18 protein expression within human pancreatic islet specimens collected from type 1 diabetics. These results further expand our knowledge of the role of IL-18 in T1D, may give insight into common pathogenic mechanisms associated with metabolic control in both T1D and T2D, and suggest that targeting this cytokine may improve therapeutic outcomes for T1D patients.

Original languageEnglish (US)
Pages (from-to)306-312
Number of pages7
JournalMolecular Immunology
Volume64
Issue number2
DOIs
StatePublished - Apr 1 2015

Fingerprint

Interleukin-18
Type 1 Diabetes Mellitus
Serum
Interleukins
Cytokines
Islets of Langerhans
Chronic Disease
Insulin

Keywords

  • Autoimmune diabetes
  • Free IL-18
  • IL-18
  • IL-18BP
  • IL-37
  • Type 1 diabetes

ASJC Scopus subject areas

  • Immunology
  • Molecular Biology

Cite this

Harms, R. Z., Yarde, D. N., Guinn, Z., Lorenzo-Arteaga, K. M., Corley, K. P., Cabrera, M. S., & Sarvetnick, N. E. (2015). Increased expression of IL-18 in the serum and islets of type 1 diabetics. Molecular Immunology, 64(2), 306-312. https://doi.org/10.1016/j.molimm.2014.12.012

Increased expression of IL-18 in the serum and islets of type 1 diabetics. / Harms, Robert Z.; Yarde, Danielle N.; Guinn, Zachary; Lorenzo-Arteaga, Kristina M.; Corley, Kevin P.; Cabrera, Monina S.; Sarvetnick, Nora E.

In: Molecular Immunology, Vol. 64, No. 2, 01.04.2015, p. 306-312.

Research output: Contribution to journalArticle

Harms, RZ, Yarde, DN, Guinn, Z, Lorenzo-Arteaga, KM, Corley, KP, Cabrera, MS & Sarvetnick, NE 2015, 'Increased expression of IL-18 in the serum and islets of type 1 diabetics', Molecular Immunology, vol. 64, no. 2, pp. 306-312. https://doi.org/10.1016/j.molimm.2014.12.012
Harms RZ, Yarde DN, Guinn Z, Lorenzo-Arteaga KM, Corley KP, Cabrera MS et al. Increased expression of IL-18 in the serum and islets of type 1 diabetics. Molecular Immunology. 2015 Apr 1;64(2):306-312. https://doi.org/10.1016/j.molimm.2014.12.012
Harms, Robert Z. ; Yarde, Danielle N. ; Guinn, Zachary ; Lorenzo-Arteaga, Kristina M. ; Corley, Kevin P. ; Cabrera, Monina S. ; Sarvetnick, Nora E. / Increased expression of IL-18 in the serum and islets of type 1 diabetics. In: Molecular Immunology. 2015 ; Vol. 64, No. 2. pp. 306-312.
@article{c0d026b2e9b74679b8a25ac4f5acda80,
title = "Increased expression of IL-18 in the serum and islets of type 1 diabetics",
abstract = "Type 1 diabetes (T1D) is a chronic disease characterized by autoimmune-mediated destruction of pancreatic insulin-producing beta cells. Interleukin (IL)-18 is a pro-inflammatory cytokine implicated in the pathogenesis of a number of inflammatory diseases. Here, we analyzed IL-18 levels in the plasma of juveniles with T1D. Compared to control subjects, IL-18 levels were significantly elevated in patients with T1D. On the other hand, levels of IL-18 binding protein (IL-18BP) and IL-37, two negative regulators of IL-18 function, remained unchanged when comparing T1D to control samples. Notably, however, although IL-18BP levels were not elevated, IL-18 and IL-18BP were found to be positively correlated in type 1 diabetics. Even so, free, unbound IL-18 remained significantly increased in diabetic patients. Additionally, correlation studies also revealed that IL-18 and IL-18BP are positively correlated with HbA1c levels in T1D patients, suggesting a potential link between IL-18 and metabolic control in these patients. Finally, we observed a significant increase in IL-18 protein expression within human pancreatic islet specimens collected from type 1 diabetics. These results further expand our knowledge of the role of IL-18 in T1D, may give insight into common pathogenic mechanisms associated with metabolic control in both T1D and T2D, and suggest that targeting this cytokine may improve therapeutic outcomes for T1D patients.",
keywords = "Autoimmune diabetes, Free IL-18, IL-18, IL-18BP, IL-37, Type 1 diabetes",
author = "Harms, {Robert Z.} and Yarde, {Danielle N.} and Zachary Guinn and Lorenzo-Arteaga, {Kristina M.} and Corley, {Kevin P.} and Cabrera, {Monina S.} and Sarvetnick, {Nora E}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.molimm.2014.12.012",
language = "English (US)",
volume = "64",
pages = "306--312",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Increased expression of IL-18 in the serum and islets of type 1 diabetics

AU - Harms, Robert Z.

AU - Yarde, Danielle N.

AU - Guinn, Zachary

AU - Lorenzo-Arteaga, Kristina M.

AU - Corley, Kevin P.

AU - Cabrera, Monina S.

AU - Sarvetnick, Nora E

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Type 1 diabetes (T1D) is a chronic disease characterized by autoimmune-mediated destruction of pancreatic insulin-producing beta cells. Interleukin (IL)-18 is a pro-inflammatory cytokine implicated in the pathogenesis of a number of inflammatory diseases. Here, we analyzed IL-18 levels in the plasma of juveniles with T1D. Compared to control subjects, IL-18 levels were significantly elevated in patients with T1D. On the other hand, levels of IL-18 binding protein (IL-18BP) and IL-37, two negative regulators of IL-18 function, remained unchanged when comparing T1D to control samples. Notably, however, although IL-18BP levels were not elevated, IL-18 and IL-18BP were found to be positively correlated in type 1 diabetics. Even so, free, unbound IL-18 remained significantly increased in diabetic patients. Additionally, correlation studies also revealed that IL-18 and IL-18BP are positively correlated with HbA1c levels in T1D patients, suggesting a potential link between IL-18 and metabolic control in these patients. Finally, we observed a significant increase in IL-18 protein expression within human pancreatic islet specimens collected from type 1 diabetics. These results further expand our knowledge of the role of IL-18 in T1D, may give insight into common pathogenic mechanisms associated with metabolic control in both T1D and T2D, and suggest that targeting this cytokine may improve therapeutic outcomes for T1D patients.

AB - Type 1 diabetes (T1D) is a chronic disease characterized by autoimmune-mediated destruction of pancreatic insulin-producing beta cells. Interleukin (IL)-18 is a pro-inflammatory cytokine implicated in the pathogenesis of a number of inflammatory diseases. Here, we analyzed IL-18 levels in the plasma of juveniles with T1D. Compared to control subjects, IL-18 levels were significantly elevated in patients with T1D. On the other hand, levels of IL-18 binding protein (IL-18BP) and IL-37, two negative regulators of IL-18 function, remained unchanged when comparing T1D to control samples. Notably, however, although IL-18BP levels were not elevated, IL-18 and IL-18BP were found to be positively correlated in type 1 diabetics. Even so, free, unbound IL-18 remained significantly increased in diabetic patients. Additionally, correlation studies also revealed that IL-18 and IL-18BP are positively correlated with HbA1c levels in T1D patients, suggesting a potential link between IL-18 and metabolic control in these patients. Finally, we observed a significant increase in IL-18 protein expression within human pancreatic islet specimens collected from type 1 diabetics. These results further expand our knowledge of the role of IL-18 in T1D, may give insight into common pathogenic mechanisms associated with metabolic control in both T1D and T2D, and suggest that targeting this cytokine may improve therapeutic outcomes for T1D patients.

KW - Autoimmune diabetes

KW - Free IL-18

KW - IL-18

KW - IL-18BP

KW - IL-37

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84920885477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920885477&partnerID=8YFLogxK

U2 - 10.1016/j.molimm.2014.12.012

DO - 10.1016/j.molimm.2014.12.012

M3 - Article

C2 - 25576800

AN - SCOPUS:84920885477

VL - 64

SP - 306

EP - 312

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

IS - 2

ER -